(Q39734462)

14 September 2017

1 reference

title

Patent ductus arteriosus in the neonate (English)

1 reference

14 September 2017

patent ductus arteriosus

1 reference

Gersony WM

1

1 reference

PubMed ID

3520463

14 September 2017

language of work or name

1 reference

1 June 1986

1 reference

Pediatric Clinics of North America

14 September 2017

1 reference

14 September 2017

33

1 reference

14 September 2017

545-560

1 reference

14 September 2017

3

1 reference

Role of prostaglandin E1 infusion in the management of transposition of the great arteries

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Bronchopulmonary dysplasia: possible relationship to pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Pathology of the ductus arteriosus treated with prostaglandins: comparisons with untreated cases

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

The response of the ductus arteriosus to prostaglandins.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Prolonged bleeding time in preterm infants receiving indomethacin for patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Medical management of small preterm infants with symptomatic patient ductus arteriosus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Patent ductus arteriosus in neonates with severe respiratory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Surgical Closure of the Ductus Arteriosus in Premature Infants

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Surgical treatment of patent ductus arteriosus in preterm infants. Four-year experience with ligation in the newborn intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Prostaglandin E1 infusion in newborns with hypoplastic left ventricle and aortic atresia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Pharmacologic closure of patent ductus arteriosus in the premature infant

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

The hemodynamic effects of intrauterine hypoxia: an experimental model in newborn lambs

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Neonatal pulmonary hypertension: pathophysiology, classification, and etiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Persistent ductus arteriosus: most probably a primary congenital malformation

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Neonatal hypoxia and pulmonary vasospasm: Response to tolazoline

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

SURGICAL LIGATION OF A PATENT DUCTUS ARTERIOSUS

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Prostaglandin E1 in suspected ductus dependent cardiac malformation

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Treatment of d-transposition of the great arteries: management of hypoxemia after balloon atrial septostomy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Effects of acetylsalicylic acid on the ductus arteriosus and circulation in fetal lambs in utero.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

The contribution of PDA in the neonate with severe RDS

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Patent ducts arteriosus in premature infants. Incidence, relation to pulmonary disease and management

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

THE RESPONSE OF THE ISOLATED DUCTUS ARTERIOSUS TO OXYGEN AND ANOXIA

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Administration of prostaglandin E1 in neonates with critical congenital cardiac defects

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Abnormal cerebral blood flow patterns in preterm infants with a large patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

The silent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Patent ductus arteriosus treated with ligation orindomethacin: A follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Preschool assessment of infants with a patent ductus arteriosus: comparison of ligation and indomethacin therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Failure of indomethacin therapy to induce closure of patent ductus arteriosus in premature infants with respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Clinical course to 1 year of age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Use of indomethacin and its relationship to retinopathy of prematurity in very low birthweight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Necrotizing enterocolitis: a prospective multicenter investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Studies on closure of the ductus arteriosus. XI. Ductal closure in utero by a prostaglandin synthetase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Studies on closure of the ductus arteriosus. XII. In utero effect of indomethacin and sodium salicylate in rats and rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Patent ductus arteriosus complicating prolongedassisted ventilation in respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Oral prostaglandin E2 in ductus-dependent pulmonary circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

The effects of prostaglandins, prostaglandin inhibitors, and oxygen on the closure of the ductus arteriosus, pulmonary arteries and umbilical vessels in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Refractory hypoxemia associated with neonatal pulmonary disease: The use and limitations of tolazoline

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Long-term prostaglandin E1 therapy in congenital heart defects.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Patent ductus arteriosus complicating the respiratory distress syndrome in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus--a double-blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Intravenous indomethacin therapy in premature infants with patent ductus arteriosus. Causes of death and one-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

Retinopathy of prematurity (ROP) and indomethacin therapy in premature infants with paten ductus arterious (PDA)

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936042-4

7 January 2021

10.1016/S0031-3955(16)36042-4

Identifiers

DOI

0 references

PubMed ID

3520463

1 reference

PubMed ID

3520463